Absolute and relative atrial fibrillation and flutter DALYs rate attributable to 2^nd level risk factors in Chile. حسب Camilo Briones-Valdivieso (21567535)

الموضوعات:

Absolute and relative hypertensive heart disease DALYs rate attributable to 2^nd level risk factors in Chile. حسب Camilo Briones-Valdivieso (21567535)

الموضوعات:

Proportion of stillbirths in Stockholm among twin and singleton pregnancies. حسب Matilda Varli Hjärne (22766125)

Grade system. حسب Zhuoyang Xia (21354186)

"…The DerSimonian–Laird random-effects model and the Cochrane Collaboration’s risk of Bias Tool were used for analysis and risk of bias assessment.…"

Literature search. حسب Zhuoyang Xia (21354186)

"…The DerSimonian–Laird random-effects model and the Cochrane Collaboration’s risk of Bias Tool were used for analysis and risk of bias assessment.…"

Study characteristics. حسب Zhuoyang Xia (21354186)

"…The DerSimonian–Laird random-effects model and the Cochrane Collaboration’s risk of Bias Tool were used for analysis and risk of bias assessment.…"

Flowchart of literature retrieval. حسب Zhuoyang Xia (21354186)

"…The DerSimonian–Laird random-effects model and the Cochrane Collaboration’s risk of Bias Tool were used for analysis and risk of bias assessment.…"

Data extraction. حسب Zhuoyang Xia (21354186)

"…The DerSimonian–Laird random-effects model and the Cochrane Collaboration’s risk of Bias Tool were used for analysis and risk of bias assessment.…"

Socio-demographic and medical characteristics of patients with liver cancer. حسب Ayana Ablayeva (22103708)

الموضوعات:

Data cleaning and preparation algorithm. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. حسب Ayana Ablayeva (22103708)

الموضوعات:

Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). حسب Ayana Ablayeva (22103708)

الموضوعات:

FPRP values for the association between rs12529 and breast cancer risk. حسب Md. Akeruzzaman Shaon (21511929)